Material Safety Data Sheet for NATIVE ENZYMES AND RELATED PROTEINS products
Non-reactive for HIV-1/HCV/ HBV by NAT, HBsAg, HCV Ab, HIV 1&2 Ab, and RPR by currently approved FDA methods. However, because no test method can offer complete assurance that infectious agents are absent, this material should be handled at the Bio-safety Level 2 (BSL 2) as recommended for any potentially infectious human serum or blood specimen in the CDC/NIH manual "Bio-safety in microbiological and Biomedical Laboratories", 1999. This material is sold for in-vitro diagnostic use only in manufacturing and research. This material is not suitable for human use. We certify this to be true to the best of our knowledge. The statements herein are offered for informational purposes only and are intended to be used solely for your consideration, investigation and verification only. It is up to the user to undertake sufficient verification and testing to determine the suitability for their own particular purpose. Use of product determined by end user.
Lee Biosolutions, Inc assumes no liability whatsoever for the accuracy or completeness of the information contained herein and are intended to be followed only by persons having related technical skill and at their own discretion and risk. Final determination of suitability of any material is the sole responsibility of the user. All materials may present unknown hazards and should be used with caution. Although certain hazards are described herein, we cannot guarantee that these are the only hazards that exits. The statements herein are offered for informational purposes only and are intended to be used solely for your consideration, investigation and verification only. It is up to the user to undertake sufficient verification and testing to determine the suitability for their own particular purpose of any information or products referred herein. Lee Biosolutions, Inc makes no warranties, expressed or implied, and assume no liability in connection with any use of this information.
Revision Date: 02/01/2012